HCW Biologics Inc. Profile Avatar - Palmy Investing

HCW Biologics Inc.

HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injecta…

Biotechnology
US, Miramar [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

HCW Biologics Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of HCWB's Analysis
CIK: 1828673 CUSIP: 40423R105 ISIN: US40423R1059 LEI: - UEI: -
Secondary Listings
HCWB has no secondary listings inside our databases.